Back

Overview on the KYU-RABLE trial

1 September 2019 (12:25 - 12:45)
Organised by:
Congress Presentation Part of: Optimal once daily oral anticoagulation use in patients undergoing catheter ablation - the European and the Japanese perspective Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Ken Okumura

Saiseikai Kumamoto Hospital, Kumamoto (Japan)

3 More presentations in this session

Presentation thumbnail
Introduction
Professor J. Kautzner (Prague, CZ) Professor K. Okumura (Kumamoto, JP)
Presentation thumbnail
Overview on the ELIMINATE-AF trial
Professor J. Kautzner (Prague, CZ)
Presentation thumbnail
Discussion
Professor J. Kautzner (Prague, CZ) Professor K. Okumura (Kumamoto, JP)

Access the full session

Session thumbnail
Optimal once daily oral anticoagulation use in patients undergoing catheter ablation - the European and the Japanese perspective

The Event

Event poster

ESC Congress 2019

1 September 2019 12:25 CET
You may be interested in
thumbnail
Congress Session
Late-Breaking Science: ablation and drug therapy
14 April 2026
thumbnail
ESC TV Today
Episode 17: Coronary sinus reducer - Best strategies to reach LDL cholesterol goals
5 June 2025
thumbnail
Congress Presentation
LOw-dose RAbeprazole therapy for reducing gastrointestinal events in patients with High Bleeding Risk (LORA-HBR): a prospective, multicenter, interventional study
1 September 2025
thumbnail
Congress Presentation
Two-year outcomes of drug-coated balloon only strategy for de novo lesions in large coronary vessels
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources